InsidersTradesSigma
Track the 亿帆医药 share price and the full directors' dealings record of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 亿帆医药 has logged 1 insider filings. Market capitalisation: €12.5bn. The latest transaction was reported on 8 February 2024 (Purchase). Among the most active insiders: 李锡明. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
亿帆医药是一家专注于医疗保健和制药领域的公司，在深圳证券交易所上市。它专注于创新药物的开发和制造。